The case for simplifying and using absolute targets for viral hepatitis elimination goals

Autor: Razavi, H. Blach, S. Razavi-Shearer, D. Abaalkhail, F. Abbas, Z. Abdallah, A. Abrao Ferreira, P. Abu Raddad, L.J. Adda, D. Agarwal, K. Aghemo, A. Ahmed, A. Al-Busafi, S.A. Al-hamoudi, W. Al-Kaabi, S. Al-Romaihi, H. Aljarallah, B. AlNaamani, K. Alqahtani, S. Alswat, K. Altraif, I. Asselah, T. Bacon, B. Bessone, F. Bizri, A.R. Block, T. Bonino, F. Brandão-Mello, C.E. Brown, K. Bruggmann, P. Brunetto, M.R. Buti, M. Cabezas, J. Calleja, J.L. Castro Batänjer, E. Chan, H.L.-Y. Chang, H. Chen, C.-J. Christensen, P.B. Chuang, W.-L. Cisneros, L. Cohen, C. Colombo, M. Conway, B. Cooper, C. Craxi, A. Crespo, J. Croes, E. Cryer, D. Cupertino de Barros, F.P. Derbala, M. Dillon, J. Doss, W. Dou, X. Doyle, J. Duberg, A.-S. Dugan, E. Dunn, R. Dusheiko, G. El Khayat, H. El-Sayed, M.H. Eshraghian, A. Esmat, G. Esteban Mur, R. Ezzat, S. Falconer, K. Fassio, E. Ferrinho, P. Flamm, S. Flisiak, R. Foster, G. Fung, J. García-Samaniego, J. Gish, R.G. Gonçales, F. Halota, W. Hamoudi, W. Hassany, M. Hatzakis, A. Hay, S. Himatt, S. Hoepelman, I.M. Hsu, Y.-C. Hui, Y.T. Hunyady, B. Jacobson, I. Janjua, N. Janssen, H. Jarcuska, P. Kabagambe, K. Kanto, T. Kao, J.-H. Kaymakoglu, S. Kershenobich, D. Khamis, F. Kim, D.J. Kim, D.Y. Kondili, L.A. Kottilil, S. Kramvis, A. Kugelmas, M. Kurosaki, M. Lacombe, K. Lagging, M. Lao, W.-C. Lavanchy, D. Lazarus, J.V. Lee, A. Lee, S.S. Levy, M. Liakina, V. Lim, Y.-S. Liu, S. Maddrey, W. Malekzadeh, R. Marinho, R.T. Mathur, P. Maticic, M. Mendes Correa, M.C. Mera, J. Merat, S. Mogawer, S. Mohamed, R. Muellhaupt, B. Muljono, D. Mostafa, I. Nahum, M.S. Nawaz, A. Negro, F. Ninburg, M. Ning, Q. Ntiri- Reid, B. Nymadawa, P. Oevrehus, A. Ormeci, N. Orrego, M. Osman, A. Oyunsuren, T. Pan, C. Papaevangelou, V. Papatheodoridis, G. Popping, S. Prasad, P. Prithiviputh, R. Qureshi, H. Ramji, A. Razavi-Shearer, K. Reddy, R. Remak, W. Richter, C. Ridruejo, E. Robaeys, G. Roberts, S. Roberts, L. Roudot-Thoraval, F. Saab, S. Said, S. Salamat, A. Sanai, F. Sanchez-Avila, J.F. Schiff, E. Schinazi, R. Sebastiani, G. Seguin-Devaux, C. Shanmugam, R.P. Sharara, A. Shilton, S. Shouval, D. Sievert, W. Simonova, M. Sohrabpour, A.A. Sonderup, M. Soza, A. Wendy Spearman, C. Steinfurth, N. Sulkowski, M. Tan, S.-S. Tanaka, J. Tashi, D. Thein, H.-H. Thompson, P. Tolmane, I. Toy, M. Valantinas, J. Van de Vijver, D. Vélez-Möller, P. Vince, A. Waked, I. Wang, S. Wedemeyer, H. Wong, V. Xie, Q. Yamada, S. Yang, H.-I. Yesmembetov, K. Yilmaz, Y. Younossi, Z. Yu, M.-L. Yuen, M.-F. Yurdaydin, C. Yusuf, A. Zekry, A. Zeuzem, S. Polaris Observatory Collaborators

The 69th World Health Assembly endorsed the Global Health Sector Strategy for Viral Hepatitis, embracing a goal to eliminate hepatitis infection as a public health threat by 2030. This was followed by the World Health Organization's (WHO) global targ

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::e372284c07cc03239a409acf66c525eb
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3000058

Hepatitis C Infection as a Risk Factor for Hypertension and Cardiovascular Diseases: An EpiTer Multicenter Study.

Autor: Rajewski P; Department of Internal and Infectious Diseases, Provincial Infectious Disease Hospital, 85-030 Bydgoszcz, Poland., Zarębska-Michaluk D; Department of Infectious Diseases, Voivodship Hospital and Jan Kochanowski University, 25-369 Kielce, Poland., Janczewska E; Hepatology Outpatient Clinic, ID Clinic, 41-400 Mysłowice, Poland., Gietka A; Department of Internal Medicine and Hepatology, Central Clinical Hospital of the Ministry of Internal Affairs and Administration, 02-507 Warsaw, Poland., Mazur W; Clinical Department of Infectious Diseases, Specialist Hospital in Chorzów, Medical University of Silesia, 40-055 Katowice, Poland., Tudrujek-Zdunek M; Department of Infectious Diseases and Hepatology, Medical University of Lublin, 20-059 Lublin, Poland., Tomasiewicz K; Department of Infectious Diseases and Hepatology, Medical University of Lublin, 20-059 Lublin, Poland., Belica-Wdowik T; Regional Center for Diagnosis and Treatment of Viral Hepatitis and Hepatology, John Paul II Hospital, 31-202 Kraków, Poland., Baka-Ćwierz B; Regional Center for Diagnosis and Treatment of Viral Hepatitis and Hepatology, John Paul II Hospital, 31-202 Kraków, Poland., Dybowska D; Department of Infectious Diseases and Hepatology, Faculty of Medicine, Collegium Medicum Bydgoszcz, Nicolaus Copernicus University, 87-100 Toruń, Poland., Halota W; Department of Infectious Diseases and Hepatology, Faculty of Medicine, Collegium Medicum Bydgoszcz, Nicolaus Copernicus University, 87-100 Toruń, Poland., Lorenc B; Pomeranian Center of Infectious Diseases, Department of Infectious Diseases, Medical University of Gdańsk, 80-210 Gdańsk, Poland., Sitko M; Department of Infectious and Tropical Diseases, Jagiellonian University Collegium Medicum, 30-252 Kraków, Poland., Garlicki A; Department of Infectious and Tropical Diseases, Jagiellonian University Collegium Medicum, 30-252 Kraków, Poland., Berak H; Hospital for Infectious Diseases in Warsaw, 01-201 Warsaw, Poland., Horban A; Hospital for Infectious Diseases in Warsaw, 01-201 Warsaw, Poland., Orłowska I; Department of Infectious Diseases and Hepatology, Wrocław Medical University, 50-367 Wrocław, Poland., Simon K; Department of Infectious Diseases and Hepatology, Wrocław Medical University, 50-367 Wrocław, Poland., Socha Ł; Department of Infectious Diseases, Hepatology and Liver Transplantation, Pomeranian Medical University, 70-204 Szczecin, Poland., Wawrzynowicz-Syczewska M; Department of Infectious Diseases, Hepatology and Liver Transplantation, Pomeranian Medical University, 70-204 Szczecin, Poland., Jaroszewicz J; Department of Infectious Diseases, Medical University of Silesia in Katowice, 41-902 Bytom, Poland., Deroń Z; Ward of Infectious Diseases and Hepatology, Biegański Regional Specialist Hospital, 91-347 Łódź, Poland., Czauż-Andrzejuk A; Department of Infectious Diseases and Hepatology, Medical University of Białystok, 15-089 Białystok, Poland., Citko J; Medical Practice of Infections, Regional Hospital, 10-561 Olsztyn, Poland., Krygier R; Infectious Diseases and Hepatology Outpatient Clinic NZOZ 'Gemini', 62-571 Żychlin, Poland., Piekarska A; Department of Infectious Diseases and Hepatology, Medical University of Łódź, 90-419 Łódź, Poland., Laurans Ł; Department of Infectious Diseases, Hepatology and Liver Transplantation, Pomeranian Medical University, 70-204 Szczecin, Poland.; Multidisciplinary Regional Hospital in Gorzów Wielkopolski, 66-400 Gorzów Wielkopolski, Poland., Dobracki W; MED-FIX Medical Center, 53-522 Wrocław, Poland., Białkowska J; Department of Infectious and Liver Diseases, Medical University of Łódź, 90-419 Łódź, Poland., Tronina O; Department of Transplantation Medicine, Nephrology, and Internal Diseases, Medical University of Warsaw, 02-091 Warsaw, Poland., Wietlicka-Piszcz M; Department of Theoretical Fundations of Biomedical Sciences and Medical Informatics, Nicolaus Copernicus University, 87-100 Toruń, Poland., Pawłowska M; Department of Infectious Diseases and Hepatology, Faculty of Medicine, Collegium Medicum Bydgoszcz, Nicolaus Copernicus University, 87-100 Toruń, Poland., Flisiak R; Department of Infectious Diseases and Hepatology, Medical University of Białystok, 15-089 Białystok, Poland.

Publikováno v: Journal of clinical medicine [J Clin Med] 2022 Sep 01; Vol. 11 (17). Date of Electronic Publication: 2022 Sep 01.

Is an 8-week regimen of glecaprevir/pibrentasvir sufficient for all hepatitis C virus infected patients in the real-world experience?

Autor: Zarębska-Michaluk D; Department of Infectious Diseases, Voivodeship Hospital, Jan Kochanowski University, Kielce, Poland., Jaroszewicz J; Department of Infectious Diseases and Hepatology, Medical University of Silesia, Katowice, Poland., Pabjan P; Department of Infectious Diseases, Voivodeship Hospital, Jan Kochanowski University, Kielce, Poland., Łapiński TW; Department of Infectious Diseases and Hepatology, Medical University of Białystok, Białystok, Poland., Mazur W; Clinical Department of Infectious Diseases, Infective Hepatology and Acquired Immunodeficiences, Medical University of Silesia, Chorzów, Poland., Krygier R; Outpatients Hepatology Department, State University of Applied Sciences, Konin, Poland., Dybowska D; Department of Infectious Diseases and Hepatology, Ludwik Rydygier Collegium Medicum, Bydgoszcz Faculty of Medicine, Nicolaus Copernicus University, Toruń, Poland., Halota W; Department of Infectious Diseases and Hepatology, Ludwik Rydygier Collegium Medicum, Bydgoszcz Faculty of Medicine, Nicolaus Copernicus University, Toruń, Poland., Pawłowska M; Department of Infectious Diseases and Hepatology, Ludwik Rydygier Collegium Medicum, Bydgoszcz Faculty of Medicine, Nicolaus Copernicus University, Toruń, Poland., Janczewska E; School of Public Health in Bytom, Department of Basic Medical Sciences; ID Clinic, Hepatology Outpatient Department, Medical University of Silesia, Bytom, Poland., Buczyńska I; Department of Infectious Diseases and Hepatology, Medical University Wrocław, Wrocław, Poland., Simon K; Department of Infectious Diseases and Hepatology, Medical University Wrocław, Wrocław, Poland., Dobracka B; Outpatient Department, MED.-FIX, Wrocław, Poland., Citko J; Medical Practice of Infections, Regional Hospital, Olsztyn, Poland., Laurans Ł; Department of Infectious Diseases, Hepatology and Liver Transplantation, Pomeranian Medical University, Szczecin, Poland.; Department of Transplantation Medicine, Nephrology, and Internal Diseases, Medical University of Warsaw, Warszawa, Poland., Tudrujek-Zdunek M; Department of Infectious Diseases, Medical University of Lublin, Lublin, Poland., Tomasiewicz K; Department of Infectious Diseases, Medical University of Lublin, Lublin, Poland., Piekarska A; Department of Infectious Diseases and Hepatology, Medical University of Łódź, Łódź, Poland., Sitko M; Department of Infectious and Tropical Diseases, Jagiellonian University, Kraków, Poland., Białkowska-Warzecha J; Department of Infectious and Liver Diseases, Medical University Łódź, Łódź, Poland., Klapaczyński J; Department of Internal Medicine and Hepatology, Central Clinical Hospital of the Ministry of Internal Affairs and Administration, Warsaw, Poland., Sobala-Szczygieł B; Department of Infectious Diseases and Hepatology, Medical University of Silesia, Katowice, Poland., Horban A; Outpatient Clinic, Hospital for Infectious Diseases, Warsaw, Poland., Berak H; Outpatient Clinic, Hospital for Infectious Diseases, Warsaw, Poland., Deroń Z; Ward of Infectious Diseases and Hepatology, Biegański Regional Specialist Hospital, Łódź, Poland., Lorenc B; Pomeranian Center of Infectious Diseases, Medical University Gdańsk, Gdańsk, Poland., Socha Ł; Outpatient Department, Multidisciplinary Regional Hospital, Gorzów Wielkopolski, Poland., Tronina O; Department of Transplantation Medicine, Nephrology, and Internal Diseases, Medical University of Warsaw, Warszawa, Poland., Flisiak R; Department of Infectious Diseases and Hepatology, Medical University of Białystok, Białystok, Poland.

Publikováno v: Journal of gastroenterology and hepatology [J Gastroenterol Hepatol] 2021 Jul; Vol. 36 (7), pp. 1944-1952. Date of Electronic Publication: 2020 Nov 23.

Week 48 Resistance Analyses of the Once-Daily, Single-Tablet Regimen Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) in Adults Living with HIV-1 from the Phase III Randomized AMBER and EMERALD Trials

Autor: Lathouwers, Erkki, Wong, Eric Y, Brown, Kimberley, Baugh, Bryan, Ghys, Anne, Jezorwski, John, Mohsine, El Ghazi, Van Landuyt, Erika, Opsomer, Magda, De Meyer, Sandra, De Wit, S, Florence, E, Vandekerckhove, L, Vandercam, B, Brunetta, J, Klein, M, Murphy, D, Rachlis, A, Walmsley, S, Ajana, F, Cotte, L, Girard, P-M, Katlama, C, Molina, J-M, Poizot-Martin, I, Raffi, F, Rey, D, Reynes, J, Teicher, E, Yazdanpanah, Y, Arasteh, K, Bickel, M, Bogner, J, Esser, S, Faetkenheuer, G, Jessen, H, Kern, W, Rockstroh, J, Spinner, C, Stellbrink, H-J, Stoehr, A, Antinori, A, Castelli, F, Chirianni, A, De Luca, A, Di Biagio, A, Galli, M, Lazzarin, A, Maggiolo, F, Maserati, R, Mussini, C, Garlicki, A, Gasiorowski, J, Halota, W, Horban, A, Parczewski, M, Piekarska, A, Belonosova, E, Chernova, O, Dushkina, N, Kulagin, V, Ryamova, E, Shuldyakov, A, Sizova, N, Tsybakova, O, Voronin, E, Yakovlev, A, Antela, A, Arribas, JR, Berenguer, J, Casado, J, Estrada, V, Galindo, MJ, Garcia Del Toro, M, Gatell, JM, Gorgolas, M, Gutierrez, F, Gutierrez, MDM, Negredo, E, Pineda, JA, Podzamczer, D, Portilla Sogorb, J, Rivero, A, Rubio, R, Viciana, P, De Los Santos, I, Clarke, A, Gazzard, BG, Johnson, MA, Orkin, C, Reeves, I, Waters, L, Benson, P, Bhatti, L, Bredeek, F, Crofoot, G, Cunningham, D, DeJesus, E, Eron, J, Felizarta, F, Franco, R, Gallant, J, Hagins, D, Henry, K, Jayaweera, D, Lucasti, C, Martorell, C, McDonald, C, McGowan, J, Mills, A, Morales-Ramirez, J, Prelutsky, D, Ramgopal, M, Rashbaum, B, Ruane, P, Slim, J, Wilkin, A, deVente, J, Moutschen, M, Van Wijngaerden, E, Vekerckhove, L, Vercam, B, Conway, B, Shafran, S

Publikováno v: AIDS Research and Human Retroviruses
AIDS Research and Human Retroviruses, Mary Ann Liebert, 2018, 36 (1), pp.48-57. ⟨10.1089/aid.2019.0111⟩
AIDS RESEARCH AND HUMAN RETROVIRUSES

Darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) 800/150/200/10 mg is being investigated in two Phase III trials, AMBER (NCT02431247; treatment-naive adults) and EMERALD (NCT02269917; treatment-experienced, virologically suppresse

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e42fe01a7f12873a66d8baa9c5f7f01
https://hdl.handle.net/11567/1096562

Oral anti-CD3 immunotherapy for HCV-nonresponders is safe, promotes regulatory T cells and decreases viral load and liver enzyme levels: results of a phase-2a placebo-controlled trial.

Autor: Halota, W.¹, Ferenci, P.², Kozielewicz, D.¹, Dybowska, D.¹, Lisovoder, N.³, Samira, S.³, Shalit, I.³, Ellis, R.³, Ilan, Y.⁴

Publikováno v: Journal of Viral Hepatitis. Aug2015, Vol. 22 Issue 8, p651-657. 7p.